FIELD: medicine.
SUBSTANCE: pharmaceutical composition for suppression of cancer metastases in individual contains fibrillar protein and pharmaceutically acceptable excipient. Said fibrillar protein is selected from group, consisting of fibrillar albumin, fibrillar serum human albumin and fibrillar capsid proteins of foot-and-mouth disease virus. To prepare said composition human fibrillar serum albumin is obtained and mixed in therapeutically effective quantity with pharmaceutically acceptable carrier.
EFFECT: increased efficiency of suppressing cancer metastases.
11 cl, 1 tbl, 33 dwg, 12 ex
| Title |
Year |
Author |
Number |
| AXL SIGNALLING INHIBITION IN ANTIMETASTATIC THERAPY |
2011 |
- Dzhacha Amato Dzh.
- Renkin Ehrin Bruno
- Kochran Dzhennifer R.
- Dzhons Duglas
- Kariolis Mikhalis
- Fu Katerin
- Mjao Juj
|
RU2556822C2 |
| METHODS FOR TREATMENT OF METASTATIC CANCER TYPES, USING AXL TRAP RECEPTORS |
2018 |
- Mcintyre Gail
- Prohaska David
- Tabibiazar Ray
|
RU2785866C2 |
| METHOD OF USING AXL AS MARKER OF EPITHELIAL-MESENCHYMAL TRANSITION |
2010 |
- Lorens Dzhejms Bredli
- Miklem Devid Robert
- Akslen Lars
|
RU2586493C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING AS AN ACTIVE INGREDIENT A FUSED PROTEIN IN WHICH A TUMOR-PENETRATING PEPTIDE AND AN ANTIANGIOGENIC AGENT ARE FUSED FOR PREVENTING AND TREATING CANCER OR ANGIOGENESIS-RELATED DISEASES |
2016 |
- Kvon, Khiuk-Sang
- Ko, Dzong-Khi
- Li, Jong-Min
- Dzung, Khiej-Joon
- Yang, Seok-Voo
- Kang, Dzae-Khoon
- Kim, Jong-Sung
|
RU2727238C2 |
| ONCOLYTIC CLOSTRIDIUM GHONII STRAINS, METHODS OF PRODUCTION AND USE |
2013 |
|
RU2667432C2 |
| ANTICANCER COMPOSITION CONTAINING A RECOMBINANT ADENOVIRUS EXPRESSING A DESTRUCTIVE FACTOR FOR AN EXTRACELLULAR MATRIX |
2017 |
|
RU2742726C2 |
| ACTIVIN-ActRIIa-Fc ANTAGONISTS AND USE THEREOF FOR TREATING OR PREVENTING BREAST CANCER |
2008 |
- Nopf Dzhon
- Sikhra Dzhasbir
- Kumar Ravindra
|
RU2473362C2 |
| BIFUNCTIONAL COMPOSITIONS FOR CANCER TREATMENT |
2019 |
|
RU2764175C1 |
| CONTROL POINT INHIBITOR AND WHOLE-CELL MICROBACTERIA FOR USE IN TREATING ONCOLOGICAL DISEASE |
2014 |
- Ekl Charlz
- Grendzh Dzhon
- Bilyard Kevin
|
RU2719934C2 |
| FUSED DLK1-Fc PROTEIN AND USING IT FOR METASTASES INHIBITION, POLYNUCLEOTIDE CODING PROTEIN, VECTOR, HOST CELL, METHOD FOR PRODUCING FUSED PROTEIN, COMPOSITION AND METHOD FOR METASTASES INHIBITION |
2010 |
- Park,Jang Voo
- Dzo,Kivon
- Li,Dongkhe
- Ju,Dzung
- Park,Dzi Khiun
- Park,Chan Voong
- Kim,Eun Dzin
- Park,Jun Dzung
|
RU2531756C2 |
